NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jun 30 04:00PM ET
29.40
Dollar change
+0.02
Percentage change
0.07
%
IndexRUT P/E64.70 EPS (ttm)0.45 Insider Own3.33% Shs Outstand46.84M Perf Week3.63%
Market Cap1.38B Forward P/E19.24 EPS next Y1.53 Insider Trans0.68% Shs Float45.28M Perf Month-1.44%
Enterprise Value1.35B PEG- EPS next Q0.27 Inst Own101.31% Short Float5.42% Perf Quarter-16.02%
Income21.18M P/S1.21 EPS this Y-24.26% Inst Trans-1.50% Short Ratio3.71 Perf Half Y-31.94%
Sales1.14B P/B1.10 EPS next Y17.98% ROA0.96% Short Interest2.46M Perf YTD-33.96%
Book/sh26.84 P/C3.32 EPS next 5Y-2.76% ROE1.73% 52W High55.74 -47.26% Perf Year12.13%
Cash/sh8.85 P/FCF11.02 EPS past 3/5Y-44.95% -28.29% ROIC1.45% 52W Low22.66 29.74% Perf 3Y-75.00%
Dividend Est.- EV/EBITDA13.36 Sales past 3/5Y-0.59% 4.39% Gross Margin43.24% Volatility2.70% 2.67% Perf 5Y-58.54%
Dividend TTM- EV/Sales1.19 EPS Y/Y TTM199.91% Oper. Margin1.11% ATR (14)0.92 Perf 10Y-24.11%
Dividend Ex-Date- Quick Ratio1.21 Sales Y/Y TTM3.00% Profit Margin1.87% RSI (14)50.03 Recom1.89
Dividend Gr. 3/5Y- - Current Ratio1.36 EPS Q/Q56.04% SMA20-1.13% Beta0.77 Target Price42.29
Payout0.00% Debt/Eq0.31 Sales Q/Q9.55% SMA500.28% Rel Volume0.59 Prev Close29.38
Employees3670 LT Debt/Eq0.16 EarningsMay 06 BMO SMA200-23.79% Avg Volume662.71K Price29.40
IPOAug 07, 2001 Option/ShortYes / Yes EPS/Sales Surpr.27.08% 3.74% Trades Volume391,519 Change0.07%
Date Action Analyst Rating Change Price Target Change
May-14-25Upgrade Wells Fargo Equal Weight → Overweight $35
Oct-31-24Downgrade BofA Securities Buy → Neutral $44 → $57
Aug-02-24Upgrade Barclays Underweight → Equal Weight $26 → $39
Jan-03-24Initiated Barclays Underweight $33
Nov-03-23Upgrade Wells Fargo Underweight → Equal Weight $39 → $28
Nov-03-23Upgrade Piper Sandler Neutral → Overweight $70 → $39
Nov-03-23Downgrade BTIG Research Buy → Neutral
Oct-11-23Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Sep-26-23Reiterated Wells Fargo Underweight $56 → $39
Aug-02-23Downgrade Piper Sandler Overweight → Neutral $66 → $70
Jun-26-25 05:58PM
Jun-16-25 11:38PM
Jun-13-25 08:42AM
Jun-06-25 09:02AM
Jun-05-25 11:31AM
05:59AM Loading…
May-31-25 05:59AM
May-22-25 01:25PM
08:30AM
May-19-25 08:33AM
May-15-25 08:55AM
May-14-25 04:01PM
08:30AM
May-07-25 01:25PM
09:20AM
03:07AM
01:35AM Loading…
01:35AM
May-06-25 07:40AM
06:43AM
06:30AM
May-02-25 10:56AM
Apr-29-25 05:06AM
Apr-28-25 09:40AM
05:04AM
Apr-27-25 01:09PM
Apr-22-25 07:29AM
Apr-14-25 04:01PM
Apr-10-25 05:08PM
09:40AM
Apr-08-25 05:12AM
Mar-25-25 09:40AM
04:01PM Loading…
Mar-24-25 04:01PM
Mar-12-25 08:30AM
Feb-28-25 08:02AM
Feb-24-25 12:00PM
Feb-11-25 09:55AM
Feb-07-25 02:11AM
Feb-06-25 07:45AM
07:06AM
06:55AM
06:30AM
Feb-05-25 08:11AM
Jan-13-25 05:47PM
Jan-08-25 04:01PM
Dec-18-24 12:20PM
Dec-12-24 12:00PM
Dec-09-24 08:30AM
Nov-29-24 11:31AM
Nov-22-24 04:01PM
Nov-21-24 09:55AM
Nov-20-24 02:00AM
Nov-18-24 04:12PM
Nov-06-24 12:20PM
Oct-31-24 09:15AM
07:00AM
Oct-30-24 04:25PM
07:45AM
06:41AM
06:30AM
Oct-11-24 12:14PM
Oct-07-24 05:35PM
Oct-04-24 12:00PM
Sep-25-24 04:01PM
Aug-28-24 12:20PM
Aug-21-24 09:04AM
Aug-20-24 04:30PM
Aug-15-24 04:01PM
Aug-02-24 09:23AM
Aug-01-24 09:00AM
07:45AM
06:43AM
06:30AM
Jul-25-24 10:02AM
Jul-24-24 07:50AM
Jul-15-24 04:01PM
Jul-03-24 11:39AM
Jun-10-24 08:33AM
Jun-03-24 11:37AM
May-06-24 04:23PM
08:02AM
May-03-24 04:01PM
12:13PM
03:11AM
May-02-24 10:44PM
01:34PM
12:54PM
08:56AM
08:45AM
07:44AM
07:30AM
Apr-22-24 04:05PM
Apr-16-24 04:01PM
Apr-08-24 04:01PM
Mar-27-24 07:49AM
07:38AM
Mar-19-24 04:27PM
Mar-11-24 05:11PM
Mar-01-24 08:43AM
Feb-23-24 05:15AM
Feb-12-24 07:43AM
Feb-09-24 10:21AM
Omnicell, Inc. engages in the provision of medication management automation solutions and adherence tools for healthcare systems and pharmacies. Its solutions include intelligence, platform and interoperability, central pharmacy dispensing, medication adherence, population health and point of care automation. The company was founded by Randall A. Lipps in September 1992 and is headquartered in Fort Worth, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LIPPS RANDALL ACHAIRMAN, PRESIDENT AND CEOMar 14 '25Buy33.1310,561349,874333,610Mar 18 04:13 PM
PARRISH MARK WDirectorDec 10 '24Sale47.3012,000567,63858,427Dec 12 04:03 PM
PARRISH MARK WDirectorDec 10 '24Proposed Sale46.0012,000552,000Dec 10 04:51 PM